- Motley Fool•4 hours ago
Investors should benefit from these biotechs' cholesterol drugs.
- Business Wire•2 days ago
Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, announced today that management will present a company overview at the 16th Annual Needham Healthcare Conference on Wednesday, April 5, 2017 at 11:20 am ET at the Westin Grand Central Hotel in New York City.
- Investor's Business Daily•7 days ago
Regeneron expects to top Amgen's recent heart-drug study in a team-up with Sanofi.
ALNY : Summary for Alnylam Pharmaceuticals, Inc. - Yahoo Finance
Alnylam Pharmaceuticals, Inc. (ALNY)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||50.45 x 100|
|Ask||56.43 x 200|
|Day's Range||50.70 - 52.81|
|52 Week Range||31.38 - 80.11|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-10.70|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|